Predilection site and risk factor of second primary cancer: A pan-cancer analysis based on the SEER database.

Author: Shan XIONG ¹ ; Hengrui LIANG ¹ ; Peng LIANG ¹ ; Xiuyu CAI ² ; Caichen LI ¹ ; Ran ZHONG ¹ ; Jianfu LI ¹ ; Bo CHENG ¹ ; Feng ZHU ³ ; Limin OU ⁴ ; Zisheng CHEN ¹ ; Yi ZHAO ¹ ; Hongsheng DENG ¹ ; Zhuxing CHEN ¹ ; Zhichao LIU ⁵ ; Zhanhong XIE ¹ ; Feng LI ¹ ; Jianxing HE ¹ ; Wenhua LIANG ¹
Author Information

1. Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong 510120, China.
2. Department of General Internal Medicine, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, Guangdong 510160, China.
3. Department of General Internal Medicine, Detroit Médica Center Sinai-Grace Hospital, Detroit MI 48235, USA.
4. Department of Oncology, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong 510660, China.
5. Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China.
Publication Type:Journal Article
MeSH: Humans; Neoplasms, Second Primary/epidemiology*; Neoplasms/epidemiology*; Risk Factors; Prognosis
From: Chinese Medical Journal 2023;136(12):1500-1502
CountryChina
Language:English